Area of research
Epidemiology · Genetics
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Inflammatory Bowel Disease, Gut microbiota and health, and Adipokines, Inflammation, and Metabolic Diseases.
Response-guided bulevirtide ± pegylated interferon alfa-2a: long-term outcomes observed in the nationwide Austrian hepatitis D cohort study.
Multi-modal atlas of lifestyle interventions reveals malleability of ageing-linked molecular features
Longitudinal multi-omic evaluation of biomarkers of health and ageing over smoking cessation intervention
Systemic multi-omic remodelling underlies health benefits of intermittent fasting
Filgotinib bei Colitis ulcerosa: ein Review
A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma.
The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
Tofacitinib-Induced Modulation of Intestinal Adaptive and Innate Immunity and Factors Driving Cellular and Systemic Pharmacokinetics.
Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines
Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade.
B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19.
Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study.
Microbial Butyrate Synthesis Indicates Therapeutic Efficacy of Azathioprine in IBD Patients.
When the genome bluffs: a tandem duplication event during generation of a novel Agmo knockout mouse model fools routine genotyping.
Alpha-1 antitrypsin governs alcohol-related liver disease in mice and humans.
Increased Fecal Neopterin Parallels Gastrointestinal Symptoms in COVID-19.
Immunologically relevant aspects of the new COVID-19 vaccines-an ÖGAI (Austrian Society for Allergology and Immunology) and AeDA (German Society for Applied Allergology) position paper.
Immunologisch relevante Aspekte der neuen COVID-19-Impfstoffe : Ein Positionspapier der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI) und des Ärzteverbands Deutscher Allergologen (AeDA).
B and T Cell Response to SARS-CoV-2 Vaccination in Health Care Professionals With and Without Previous COVID-19
Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines
Dietary lipids fuel GPX4-restricted enteritis resembling Crohn's disease.
Prebiotic Effects of Partially Hydrolyzed Guar Gum on the Composition and Function of the Human Microbiota—Results from the PAGODA Trial
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease.
Targeting NAD immunometabolism limits severe graft-versus-host disease and has potent antileukemic activity.
IBD in the time of corona - vigilance for immune-mediated diseases.
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting.
Nuclear Receptors Regulate Intestinal Inflammation in the Context of IBD.
The Arachidonic Acid Metabolome Serves as a Conserved Regulator of Cholesterol Metabolism
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus
Heterogeneity of fibrosis patterns in non‐alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways